Molipaxin
In brief
- In our pharmacy, you can buy molipaxin without a prescription, with delivery in 5–14 days throughout the United Kingdom. Discreet and anonymous packaging.
- Molipaxin (trazodone) is used for major depressive disorder and is commonly used off‑label for insomnia and sleep disturbances; it is a serotonin antagonist and reuptake inhibitor (SARI) that blocks certain 5‑HT receptors and inhibits serotonin reuptake, with additional antihistaminic and alpha‑adrenergic blocking effects.
- The usual dosage for depression starts at around 150 mg per day in divided doses, with outpatient doses up to 400 mg/day (and up to 600 mg/day in hospital settings); for insomnia, off‑label bedtime doses are typically 25–100 mg, usually not exceeding 150 mg.
- The form of administration is oral: immediate‑release tablets (50–300 mg), extended‑release/prolonged‑release tablets, capsules and oral solution formulations (varies by market).
- The effect for sleep typically begins within 25–60 minutes; antidepressant benefits may begin in 1–2 weeks with full effect commonly seen in 4–6 weeks.
- The duration of action for sedative effects is generally about 6–8 hours for immediate‑release formulations; antidepressant effects are maintained with regular daily dosing.
- Do not consume alcohol with molipaxin — alcohol increases drowsiness and the risk of respiratory depression, severe sedation and hypotension.
- The most common side effec is drowsiness/sedation.
- Would you like to try molipaxin without a prescription?
Basic Molipaxin Information
- INN (International Nonproprietary Name): Trazodone
- Brand Names Available In United Kingdom: Trazodone (often sold by INN); some markets use Trittico in parts of Europe and other local names such as Raldesy or Trazorel in other regions.
- ATC Code: N06AX05
- Forms & Dosages: Tablets 50 mg, 100 mg, 150 mg, 300 mg; capsules; oral liquid (examples of solution strength ≈ 10 mg/mL depending on product).
- Manufacturers In United Kingdom: Original developer Pfizer (U.S.); European suppliers such as Angelini Pharma for Trittico; many generic manufacturers supply trazodone (Teva, Sandoz, Mylan, Torrent, Sun Pharma, KRKA).
- Registration Status In United Kingdom: Sold in the UK commonly by INN as a prescription medicine; brand availability and marketing authorisations vary by supplier and should be checked against product SPCs.
- OTC / Rx Classification: Prescription-only medicine (POM); never available over the counter.
Critical Warnings & Restrictions
Patient safety must come first when considering molipaxin (trazodone).
Absolute contraindications include known hypersensitivity, recent or concurrent monoamine oxidase inhibitor (MAOI) use within 14 days, and use in the acute recovery phase following myocardial infarction.
Relative cautions include cardiac disease, history of seizures, significant hepatic or renal impairment and any current risk of suicidality.
Elderly patients are at higher risk of sedation, orthostatic hypotension and falls and should start on lower doses with close monitoring.
Pregnancy and breastfeeding require specialist review to balance maternal mental health against neonatal risk and to document shared decision-making.
For safety-critical workplaces, including driving and operation of heavy machinery, UK fitness‑to‑work rules require workplace risk assessment plus clinician or pharmacist advice before resuming duties.
High‑Risk Groups
Elderly people should begin at lower doses and be monitored for daytime drowsiness and blood pressure changes.
Pregnant or breastfeeding people should discuss options with a specialist; trazodone requires individual risk/benefit assessment.
People with chronic illness such as heart disease, hepatic or renal impairment, and those with a seizure history need dose adjustments and closer review.
Interaction With Activities
Trazodone commonly causes sedation and impaired concentration, which can affect driving and workplace safety.
Employers and clinicians should perform a workplace risk assessment where duties are safety critical.
Q&A — “Can I Drive After Taking It In The UK?”
No firm guarantee can be given that you will be safe to drive after taking trazodone.
If you feel drowsy, dizzy or have impaired concentration do not drive.
Inform DVLA or occupational health only if you have a long‑term impairment that could affect driving safety and discuss timing with your prescriber and pharmacist.
- Immediate red‑flag symptoms: severe dizziness, fainting, chest pain, rapid heartbeat, suicidal thoughts.
- Monitoring checklist: baseline and periodic blood pressure, ECG if cardiac history, routine mood and suicidality assessments, falls‑prevention review at home (non‑slip rugs, raised toilet seat, mobility aids).
Usage Basics
INN, Brand Names Available In The UK
Trazodone is the International Nonproprietary Name (INN) typically used in UK practice.
It is often dispensed simply as trazodone or under generic labelling rather than a distinct UK brand name.
In other European markets the same active substance is sometimes marketed as Trittico.
Legal Classification
Trazodone is a prescription‑only medicine (POM) across the UK and is never available over the counter.
Dispensing occurs on NHS prescriptions, private prescriptions or NHS e‑prescriptions with pharmacist counselling at point of supply.
Check the MHRA and the product SPC for brand‑specific details and marketing authorisation; some brands and strengths vary by supplier.
- Common UK pharmacy chains: Boots, LloydsPharmacy, Superdrug and local independent pharmacies.
- Online pharmacy options: GPhC‑registered online pharmacies that dispense on receipt of an e‑prescription or after an online consultation.
- INN: International Nonproprietary Name.
- POM: Prescription‑Only Medicine.
- SPC: Summary of Product Characteristics.
- MHRA: Medicines and Healthcare products Regulatory Agency.
Dosing Guide
Standard Regimens
Trazodone dosing varies by indication.
For major depressive disorder a common starting total dose is 150 mg per day in divided doses with upward titration.
Outpatient maximums commonly cited are around 400 mg per day, with higher ceilings used in hospital settings (up to 600 mg per day).
For insomnia the off‑label single evening doses range from 25 mg to 100 mg, and sleep dosing usually does not exceed 150 mg.
Children are not approved for use.
Adjustments For Comorbidities
Elderly patients should start at lower doses and increase slowly while monitoring for sedation and hypotension.
Hepatic or renal impairment often requires dose reduction and specialist review; specific adjustments depend on clinical judgement and SPC guidance.
Patients with seizure history or significant cardiac disease should be reviewed by a specialist before dose escalation.
- Titration steps: start low, review after 1–2 weeks, assess effect by 4–6 weeks and adjust as clinically indicated.
- Monitoring checklist: blood pressure, falls risk, mood and suicidality assessments, sexual side‑effect enquiries.
Q&A — “What If I Miss A Dose?”
Take the missed dose as soon as you remember unless the next scheduled dose is due.
Do not double the next dose to make up.
If you are unsure, contact your pharmacist or prescriber and record missed doses for review.
Interaction Chart
Food And Drinks
Alcohol has additive sedative effects with trazodone and impairs psychomotor function.
Avoid alcohol when initiating therapy or while doses are being adjusted.
Caffeine in tea or coffee can mask sedative effects but does not prevent impairment; discuss habits with your clinician.
Common Drug Conflicts
The most serious contraindicated interaction is with MAO inhibitors; avoid MAOI use within 14 days of trazodone.
Trazodone is metabolised via hepatic CYP enzymes, notably CYP3A4.
Strong CYP3A4 inhibitors increase trazodone plasma levels and require dose adjustment and close monitoring.
Concomitant serotonergic agents, St John’s wort and certain opioids increase the risk of serotonin syndrome.
QT‑prolonging drugs and other cardiac medications may necessitate ECG monitoring.
| Drug/Class | Interaction Type | Practical Advice |
|---|---|---|
| MAO Inhibitors | Contraindicated; risk of serotonin syndrome | Do not co‑prescribe; avoid within 14 days of MAOI use |
| Strong CYP3A4 Inhibitors (e.g. ketoconazole, clarithromycin) | Increased trazodone levels | Consider dose reduction and enhanced monitoring |
| SSRIs, SNRIs, St John’s Wort | Serotonergic additive effect | Monitor for serotonin syndrome; review combination necessity |
| QT‑prolonging Drugs (e.g. certain antiarrhythmics) | Increased arrhythmia risk | ECG monitoring advised if clinically indicated |
| Alcohol and Sedative Antihistamines | Additive sedation | Avoid during initiation and dose changes |
- Dietary cautions: avoid alcohol while starting or changing dose; moderate caffeine intake and report herbal supplement use.
- What to bring to your pharmacy or GP: a full current medication list including OTC and herbal remedies, recent alcohol use pattern and any allergy history.
User Reports & Trends
Patient discussions on NHS Choices, Patient.info and community forums frequently report early sedation and improved sleep when trazodone is used for insomnia.
Dry mouth, dizziness and occasional orthostatic hypotension are commonly described.
Sexual dysfunction appears less prominent than with some SSRIs in many patient reports, but individual experiences vary.
Search activity shows some patients using the search term molipaxin as an alternative to trazodone when asking about sourcing and cost.
- Efficacy For Sleep
- Sedation And Daytime Drowsiness
- Dosing Confusion During Titration
- Drug Interactions And Safety Concerns
- Access And Cost Questions
- Monitoring And Follow‑Up Worries
| Side Effect | Reported Frequency | Advice |
|---|---|---|
| Drowsiness/Sedation | Common | Take at night; review dose if persistent |
| Dry Mouth | Common | Frequent sips of water; report if severe |
| Dizziness/Orthostatic Hypotension | Common in elderly | Stand slowly; monitor BP |
Access & Purchase Options
Boots, LloydsPharmacy, Superdrug
Trazodone is prescription‑only and is supplied via NHS GP prescriptions, private prescriptions or NHS e‑prescriptions to community pharmacies such as Boots, LloydsPharmacy, Superdrug and independent pharmacies.
Pharmacists provide counselling at supply and can check interactions and monitoring needs.
Online Pharmacies And NHS E‑Prescriptions
GPhC‑registered online pharmacies can dispense trazodone on receipt of an electronic prescription or after an online consultation.
Patients should verify pharmacy registration with the General Pharmaceutical Council and check for contactable pharmacist support.
Cross‑border imports and unlicensed online sellers carry risks including counterfeit products and incorrect dosing; avoid these sources.
- Safe online purchase checklist: GPhC registration, MHRA warnings available, product leaflet/SPC provided, contactable pharmacist listed.
| Step | In‑Store | Online |
|---|---|---|
| Prescription Submission | Hand in paper or NHS electronic prescription | Upload or forward e‑prescription after consultation |
| Counselling | Verbal counselling at collection | Phone or video counselling with pharmacist |
| Medication Review | Opportunity at point of supply | Pharmacist review prior to dispensing |
In our online pharmacy, molipaxin is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
Mechanism & Pharmacology
Simplified Explanation
Trazodone acts as a serotonin antagonist and reuptake inhibitor with 5‑HT2 receptor antagonism and alpha‑adrenergic blocking properties.
These combined actions contribute to antidepressant effects and the commonly observed sedative properties that are useful for insomnia at lower doses.
Clinical Terms
ATC code N06AX05 places trazodone in the “other antidepressants” group.
Immediate and prolonged‑release formulations exist and hepatic CYP metabolism (notably CYP3A4) affects interactions and dosing considerations in hepatic impairment.
- INN: International Nonproprietary Name.
- ATC Code: N06AX05 — antidepressant class code.
- CYP3A4: Key hepatic enzyme involved in trazodone metabolism.
- SPC: Summary of Product Characteristics for brand details.
| Mechanism | Clinical Effect | Monitoring Need |
|---|---|---|
| Serotonin reuptake inhibition + 5‑HT2 antagonism | Antidepressant effect; improved sleep | Mood assessment, suicidality monitoring |
| Alpha‑adrenergic blockade | Orthostatic hypotension; sedation | BP checks, falls prevention |
Indications & Off‑Label Uses
MHRA‑Approved Uses
Licensed indications centre on treatment of major depressive disorder, though national marketing authorisations and labelling can vary by country and brand.
Off‑Label Practices In NHS And Private Care
Common off‑label uses in UK practice include low‑dose evening use for insomnia and adjunctive treatment for anxiety‑related sleep disturbance.
Private psychiatrists may consider trazodone for refractory depression when SSRIs have been insufficient, often using it alongside management of insomnia.
Paediatric use is not approved and should be avoided unless directed by a specialist.
- Licensed Uses: Major depressive disorder per product authorisation.
- Off‑Label Uses: Low‑dose insomnia treatment, adjunctive sleep management, anxiety‑related sleep disturbance.
- Off‑Label Checklist For Clinicians: review evidence, obtain informed consent, document rationale, set monitoring plan.
Key Clinical Findings
Antidepressant effects may begin within 1–2 weeks with fuller response by 4–6 weeks.
Treatments are generally continued for several months after improvement to reduce relapse.
Lower doses produce sedative effects useful for insomnia, but licensing for sleep depends on the product SPC and national guidance.
Overdose risks include severe drowsiness, hypotension, arrhythmia and serotonin syndrome — urgent care is required for suspected overdose.
Elderly and cardiac patients should be considered for ECG monitoring when clinically indicated and high doses avoided without specialist input.
- Monitoring Timeline: baseline BP/HR, review at 1–2 weeks, reassess at 4–6 weeks, then routine follow‑up.
| Item | Onset / Review Point | Red‑Flag Signs |
|---|---|---|
| Antidepressant effect | 1–2 weeks (initial), 4–6 weeks (full) | Worsening mood, suicidal thoughts |
| Cardiac risk | Consider ECG at baseline if cardiac history | Syncope, palpitations, chest pain |
Alternatives Matrix
NHS Prescribing Alternatives
| Drug (INN) | Typical Indication | Sedation Profile | Anticholinergic Burden | Sexual Side‑Effects | Key Monitoring |
|---|---|---|---|---|---|
| Mirtazapine | Depression, insomnia | High (sedating) | Low | Low | Weight, lipids, mood |
| Amitriptyline | Depression, neuropathic pain, insomnia | High | High | Moderate | ECG in cardiac risk, anticholinergic effects |
| Sertraline | Depression, anxiety | Low | Low | Moderate | Monitor nausea, sexual function |
| Paroxetine | Depression, anxiety | Low | Low | Moderate to high | Withdrawal risk on stopping |
Pros And Cons Checklist
- Consider trazodone when sleep improvement is needed alongside antidepressant effect.
- Mirtazapine is useful if sedation is desired but may increase appetite and weight.
- Amitriptyline carries greater anticholinergic and cardiac risks and requires more monitoring in older patients.
- SSRIs such as sertraline are less sedating and often preferred first‑line for depression without insomnia.
- Substitution Steps: document rationale, plan stop/start and tapering, monitor for withdrawal or recurrence of symptoms.
Common Questions
Will It Make Me Sleepy All Day?
Initial sedation is common, especially when starting or after dose increases.
Timing the dose at night and gradual titration often reduces daytime sleepiness.
How Long Until It Works?
Some benefit may occur within 1–2 weeks with fuller antidepressant effect by 4–6 weeks.
Can I Drink Alcohol?
Avoid alcohol when starting trazodone or when doses change because of additive sedation and impaired judgement.
Is It Addictive?
Trazodone is not classically addictive, but abrupt stopping can cause withdrawal‑like effects; taper gradually when discontinuing.
Report any worsening mood or suicidal thoughts immediately to NHS 111, your GP or emergency services.
NHS Cost & Access Comparison Table
| Source | Typical Price Range (Private) | NHS Prescription Charge Applicability | Exemption Status | Notes |
|---|---|---|---|---|
| NHS GP Prescription | Varies — typically generic pricing | Subject to NHS prescription charges in England | Exemptions apply (age, benefits, pregnancy) | Check local formulary and GP for repeat prescriptions |
| Boots / LloydsPharmacy / Superdrug | Private price varies by brand and dispensing fee | Not applicable for private prescriptions | Not applicable | Branded vs generic affects cost |
| Online Private Pharmacy | Private prescription and dispensing fees apply | Not applicable | Not applicable | Check GPhC registration and reviews |
| Region | Prescription Payment Policy | Notes |
|---|---|---|
| England | Standard NHS prescription charges apply (unless exempt) | Check current NHS charge levels |
| Scotland | Prescriptions are free of charge | Regional NHS rules apply |
| Wales | Prescriptions are free of charge | Regional NHS rules apply |
| Northern Ireland | Prescriptions are free of charge | Regional NHS rules apply |
- Repeat Prescription Checklist: proof of identity for new patients, GP review date, use electronic prescribing services where available.
Registration & Regulation
MHRA Approval Process
The MHRA oversees licensing and post‑marketing safety in the UK.
Individual brands hold UK marketing authorisations and the SPC should be consulted for brand‑specific dosing and contraindications.
Check the SPC for up‑to‑date safety information.
NHS Prescribing Framework
GPs prescribe according to NICE guidance and local formularies; specialists manage complex cases.
The Yellow Card scheme is used to report suspected adverse drug reactions; patients and clinicians are encouraged to report serious or unexpected events.
- SPC checks for dosing and contraindications.
- Yellow Card reporting for serious adverse events such as serotonin syndrome or cardiac events.
- Licensed versus unlicensed importation requires MHRA guidance compliance.
- MHRA: UK medicines regulator.
- SPC: product Summary of Product Characteristics.
- Yellow Card: adverse reaction reporting scheme.
Storage & Handling
UK Household Storage
Store trazodone at room temperature, ideally between 15°C and 30°C, protected from moisture and light.
Because UK homes can be humid, keep tablets in a dry cupboard away from bathrooms and kitchen steam.
Keep medicines in original packaging with the leaflet to preserve expiry and batch information.
Guidance From NHS And Pharmacists
For liquid formulations ensure bottles are tightly capped and follow any manufacturer guidance about expiry after opening.
Keep all medicines out of reach of children and pets and return unused medication to a pharmacy for safe disposal.
- Safe Storage Checklist: correct temperature range, dry location, child safety, check expiry dates.
Guidelines For Proper Use
UK Pharmacist Counselling Style
Pharmacists should confirm the indication and dosing schedule and advise about sedation and driving risk.
Review concurrent medicines including OTC and herbal remedies and discuss simple side‑effect measures such as sipping water for dry mouth or standing slowly for dizziness.
Document patient understanding and consent on the clinical record where possible.
NHS Patient Safety Advice
Arrange follow‑ups at 1–2 weeks and 4–6 weeks with baseline blood pressure and consideration of ECG if cardiac risk exists.
Maintain suicide risk monitoring for younger adults and those with prior ideation.
When discontinuing, emphasise gradual tapering to reduce withdrawal symptoms.
- POM: prescription requirement reminder.
- ATC Code: N06AX05.
- SPC: check for brand specifics.
- First‑Dispense Counselling Checklist: what to expect, potential red flags, monitoring schedule, pharmacist/GP contact numbers for urgent advice.
Delivery Across United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | Greater London | 5-7 days |
| Birmingham | West Midlands | 5-7 days |
| Manchester | Greater Manchester | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Leeds | West Yorkshire | 5-7 days |
| Liverpool | Merseyside | 5-7 days |
| Bristol | South West England | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Sheffield | South Yorkshire | 5-7 days |
| Newcastle Upon Tyne | North East England | 5-7 days |
| Belfast | Northern Ireland | 5-7 days |
| Cardiff | Wales | 5-7 days |
| Plymouth | South West England | 5-9 days |